Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39050

DNAH5 Knockout NCI-H1975 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

This CRISPR/Cas9-edited polyclonal knockout cell population targets DNAH5 in the NCI-H1975 human non-small cell lung cancer line, which carries EGFR exon 19 deletion and TP53 mutation. DNAH5 encodes the axonemal dynein heavy chain 5, a core outer dynein arm component essential for ciliary motility and mucociliary clearance, and is transcriptionally controlled by FOXJ1 and RFX3. Disruption of DNAH5 impairs ciliary function, perturbing mucociliary clearance and potentially Hedgehog signaling, and facilitates research on primary ciliary dyskinesia, ciliopathies, and cancer cell migration. Representative assays include immunofluorescence, ciliary beat frequency analysis, and cell migration assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1975

    Sex of Donor

    Female

    Gene Name

    DNAH5

    Gene Identifier

    NCBI Gene ID 1767

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAH5 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population that disrupts DNAH5 in human lung adenocarcinoma epithelium. This heterogeneous pool of NCI-H1975 cells harbors diverse Cas9-induced locus disruptions, generating a loss-of-function model for ciliary research without clonal selection. The polyclonal format captures multiple editing outcomes, enabling robust, population-level phenotypic analyses suited for studies of ciliary motility and mucociliary clearance.

NCI-H1975 is a well-characterized NSCLC line from a non-smoker female??s lung adenocarcinoma pleural effusion, carrying activating EGFR exon 19 deletion and mutant TP53. Serum starvation induces primary cilia in these cells, providing a transformed epithelial background for studying ciliary structure and function. This context uniquely permits investigation of ciliary defects alongside oncogenic signaling perturbations.

DNAH5 encodes axonemal dynein heavy chain 5, an outer dynein arm core component that generates ciliary beat force essential for mucociliary clearance. FOXJ1 and RFX3 are key transcriptional regulators, while Notch and Wnt pathways modulate its expression. DNAH5 assembles with DNAI1, DNAI2, DNAL1, and the outer dynein arm docking complex into a functional motor. Knockout of DNAH5 disrupts ciliary motility, abrogating mucociliary transport and potentially deregulating Hedgehog signaling, which depends on intact cilia for Gli transcription factor processing.

DNAH5 knockout in NCI-H1975 recapitulates key primary ciliary dyskinesia features like defective mucociliary clearance and may reveal ciliary roles in cancer cell migration and invasion. These cells?? primary cilia allow direct measurement of ciliary beat frequency, structural integrity, and signaling, linking ciliary dysfunction to Kartagener syndrome and tumor biology. This model bridges genetic ciliopathies and cancer research, enabling dissection of ciliary functions in epithelial homeostasis.

Applications include mechanistic studies of ciliary motility, high-content screening for ciliopathy-modifying compounds, and NSCLC cilia research. Key assays are immunofluorescence for acetylated ??-tubulin and Arl13b, western blotting and RT-qPCR for DNAH5 expression, ciliary beat frequency videomicroscopy, mucociliary clearance assays with fluorescent microspheres, and wound-healing/Transwell migration assays. Hedgehog pathway activity can be assessed with Gli-responsive luciferase reporters. For more information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)